XIFIN and vRad Partner to Integrate Pathology and Radiology Workflows for Consolidated Diagnostic Reports
vRad (Virtual Radiologic), the nation’s leading telemedicine company and radiology practice, and XIFIN, Inc., the leading provider of financial and health economic optimization solutions for diagnostic service providers, announced the companies intend to create an online collaborative clinical workflow to facilitate consolidated diagnostic reports (CDR) of radiology, pathology and clinical laboratory results. The online solution will initially be designed to support referring oncologists and their patients.
Radiology and pathology images and reports are essential to facilitate accurate diagnoses for appropriate diagnostic management and treatment decisions for cancer patients. By integrating all testing results and digital images from both diagnostic specialties, the CDR provided by vRad and XIFIN will provide a more efficient, collaborative tool for physicians, breaking down current diagnostic silos. The CDR will allow pathologists and radiologists to provide the full picture of patient diagnostics, highlight and reduce clinical discordance, and enable faster and more precise diagnoses.
“Leading health institutions have proven that when radiologists and pathologists collaborate, patients get better care at lower costs to themselves and the healthcare system as a whole,” said Lâle White, CEO of XIFIN. “vRad built a patented workflow platform that made it possible to offer best-in-class radiology services on a truly global scale; XIFIN’s health economics optimization platform has achieved the same level of service and scalability within pathology. Together, we have an opportunity to better serve clinicians and their patients by combining our proven technology, collaboration and workflow platforms into something even more powerful.”
While pathology and radiology workflows have traditionally been independent of each other, the accelerated adoption of digital pathology, similar to the digital transformation radiology experienced in the 2000s, has opened the opportunity for both companies to develop the CDR using their existing technology platforms: XIFIN’s ProNet, a comprehensive online information and digital consultation forum for global pathology; and vRad’s patented clinical and imaging global platform that is the world’s biggest and most advanced teleradiology PACS, moving over 1.3 billion radiology images in 2014.
“XIFIN and vRad are uniquely positioned to innovate by combining our technology platforms and industry-leading clinical services to challenge and transform traditional diagnostic reporting,” said Jim Burke, President and CEO of vRad. “Our collaboration with XIFIN has many facets that can benefit radiology and pathology services. We see much potential to combine our clinical and technical expertise to improve coordinated care for physicians and their patients.”
XIFIN, Inc. is an innovative software and services company dedicated to optimizing the economics of healthcare. The company’s cloud-based technology and business intelligence platform links healthcare stakeholders in the delivery and reimbursement of care, optimizing both business and patient outcomes and providing informed, streamlined diagnostic and business decision-making. The company processes more than 200 million claims per year on behalf of its clients, who have cumulatively realized over $2 billion in incremental net cash collections. XIFIN has received continual industry recognition, including named to the Inc. 5000 list of fastest growing privately held companies for eight years, and ranking among Deloitte’s Technology Fast 500. To learn more, visit www.XIFIN.com, or follow XIFIN on Twitter and LinkedIn.
vRad (Virtual Radiologic) is a global telemedicine company and the nation’s leading radiology practice with over 350 U.S. board-certified physicians, 75% of whom are subspecialty trained. We interpret over 5 million patient studies annually—and process over 1 billion images on the world’s biggest and most advanced teleradiology PACS—for our 2,100+ client hospital, health system and radiology group facilities. A winner of Frost & Sullivan’s Visionary Innovation Award for Medical Imaging Analytics (North America) and a leader in imaging analytics, vRad provides access to the only radiology patient care benchmarking platform (vRad RPCSM Index) with 30 million+ patient studies, growing at 400,000 studies per month. vRad’s clinical expertise and evidence-based insight help clients make better decisions for the health of their patients and their imaging services. For more information, please visit www.vrad.com. Follow us on Twitter, Facebook and LinkedIn.